ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 53,136,600
Number of holders: 56
Total 13F shares, excl. options: 27,250,196
Shares change: +27,250,196
Total reported value, excl. options: $1,027,708,220
Value change: +$1,027,708,283
Number of buys: 56
Price: $37.74

Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q3 2020

56 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q3 2020.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,250,196 shares of 53,136,600 outstanding shares and own 51.28% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9,699,925 shares), Vivo Capital, LLC (4,220,048 shares), Logos Global Management LP (3,136,981 shares), Board of Trustees of The Leland Stanford Junior University (1,446,854 shares), WELLINGTON MANAGEMENT GROUP LLP (1,034,528 shares), Foresite Capital Management IV, LLC (973,514 shares), Cormorant Asset Management, LP (971,770 shares), BlackRock Inc. (829,014 shares), FMR LLC (748,830 shares), and VANGUARD GROUP INC (645,382 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.